Stephen P. Hunger
Chaired the COG leukaemia committee through the era that pushed childhood ALL cure rates above 90%.
Overview
Stephen Hunger chaired the Children's Oncology Group acute lymphoblastic leukaemia committee from 2008 to 2016 and led the analyses documenting improved survival across successive trials, the Ph-like ALL discovery work with Charles Mullighan, and the trials that added imatinib to chemotherapy for Philadelphia-positive ALL. He co-authored the NEJM review of childhood ALL and leads oncology at CHOP.
Pages like this
not linked directly; found by shared links- PersonSumit Gupta
Shares COG AALL1731, Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL, Blinatumomab, Acute lymphoblastic leukaemia and the tags paediatric, all.
- PersonRachel E. Rau
Shares COG AALL1731, Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL, Blinatumomab, Acute lymphoblastic leukaemia.
- PersonNicola Gökbuget
Shares Blinatumomab, Acute lymphoblastic leukaemia and the tags all, cooperative-group.
- PairingBlinatumomab added to frontline chemotherapy
Shares COG AALL1731, Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL, Blinatumomab, Acute lymphoblastic leukaemia.
- PersonChing-Hon Pui
Shares Acute lymphoblastic leukaemia and the tags paediatric, all.
- PersonJeffrey S. Dome
Shares the tags paediatric, cooperative-group.
- PersonKara M. Kelly
Shares the tags paediatric, cooperative-group.
- PersonRuth Ladenstein
Shares the tags paediatric, cooperative-group.